About
Press Releases
Tools
Providers
Parents
Contact
Chat
How To Order
Publications
Blog
Case Studies
Resources
Guidelines
How To Order
Contact
Chat
Tools
About
Blog
|
8.9.2018
Chromosomal Microarray (CMA) in Children with Psychiatric Disorders: Who to Test and What to Expect
News
|
3.5.2011
Medical discovery in Utah aided by federal program Michael Paul
Press Releases
|
9.14.2020
Bionano Genomics Expands Its Diagnostic Testing Menu with Launch of Lineagen’s EpiPanelDx PLUS Gene Panel...
What's new
Close
Blog
Genetic testing framework for neurodevelopmental disorders and epilepsy plus
March 6, 2018
Chromosomal Microarray with reflex to whole exome sequencing: beneficial genetic testing process for patients with neurodevelopmental disorders and patients with epilepsy plus.
Lauren Miller, MS, LCGC
Read more
Lastest News
Chromosomal Microarray (CMA) in Children with Psychiatric Disorders: Who to Test and What to Expect
Another great year contributing and sharing at ACMG 2018 in Charlotte, NC
Looking Outside of Guidelines for Genetic Testing
Pharmacogenetics: Looking toward the future with personalized medicine
Frequently Asked Questions (FAQ) with our Lineagen Genetic Counselors
Archives
August 2018
April 2018
March 2018
Tags
CMA
Conference
epilepsy
FAQ
PGx
WES
Press Releases
Michael Paul, Ph.D., CEO of Lineagen, Inc., Nominated for Prestigious Entrepreneur of the Year Award
Lineagen Announces Identification of New Genetic Region Associated with Seizures in Wolf-Hirschhorn
Lineagen Announces Launch of Proprietary Variant Index to Improve Interpretation of Genetic Basis fo
Publications
Identification of Rare Recurrent Copy Number Variants in High-Risk Autism Families and Their Prevale
American College of Medical Genetics recommendations for the design and performance expectations for
How physicians use array comparative genomic hybridization results to guide patient management in ch